Literature DB >> 11206226

Treatment of malignancy arising in pilonidal disease.

E de Bree1, F A Zoetmulder, M Christodoulakis, B M Aleman, D D Tsiftsis.   

Abstract

BACKGROUND: Malignant degeneration is a rare complication of pilonidal disease and is associated with a high recurrence rate and poor prognosis compared with regular nonmelanoma skin cancer. Treatment in our departments and in the international literature was evaluated.
METHODS: We analyzed the data from three patients with malignant degeneration who were treated in our departments and an additional 56 patients who were found after an extensive literature search.
RESULTS: A total of 47 males and 12 females, with a mean age of 52 years, were most frequently primarily treated with surgery. After a mean follow-up time of 28 months, 20% of all patients died with evidence of disease and an additional 10% died of unrelated causes. The overall recurrence rate was 39%, with a median time to recurrence of only 9 months. The local recurrence rate was lower when radiotherapy was added to surgical treatment alone (30% vs. 44%). Re-excision of local recurrence resulted in some long-term survivals.
CONCLUSIONS: Early diagnosis and treatment may lead to improvement of the relative poor prognosis. Surgical treatment should be tailored according to the locoregional extent. The high recurrence rate after surgical treatment can be reduced by the addition of radiotherapy. Although repeat surgery for recurrent disease may involve extensive resection and morbidity, this may result in prolonged survival.

Entities:  

Mesh:

Year:  2001        PMID: 11206226     DOI: 10.1007/s10434-001-0011-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  13 in total

1.  Squamous cell carcinoma arising in a neglected pilonidal sinus.

Authors:  K Atmatzidis; T Pavlidis; B Papaziogas; K Psaralexis; T Papaziogas
Journal:  Int J Colorectal Dis       Date:  2002-03       Impact factor: 2.571

2.  Recurrent squamous cell carcinoma arising in a neglected pilonidal sinus: report of a case and literature review.

Authors:  Ramazan Eryılmaz; Tuna Bilecik; Ismail Okan; Orhan Veli Ozkan; Aytekin Coşkun; Mustafa Sahin
Journal:  Int J Clin Exp Med       Date:  2014-02-15

3.  Squamous cell carcinoma arising from pilonidal sinus.

Authors:  Mithilesh K Pandey; Puneet Gupta; Ajay K Khanna
Journal:  Int Wound J       Date:  2012-10-11       Impact factor: 3.315

4.  Pilonidal sinus disease: risk factors for postoperative complications and recurrence.

Authors:  Akin Onder; Sadullah Girgin; Murat Kapan; Mehmet Toker; Zulfu Arikanoglu; Yilmaz Palanci; Bilsel Bac
Journal:  Int Surg       Date:  2012 Jul-Sep

5.  Verrucous carcinoma (Buschke-Lowenstein) arising in a sacrococcygeal pilonidal sinus tract: report of a case.

Authors:  Oner Mentes; Metin Akbulut; Mahir Bagci
Journal:  Langenbecks Arch Surg       Date:  2007-07-03       Impact factor: 3.445

6.  CT appearances of Marjolin's ulcer in the left gluteal region of a young man.

Authors:  Si Mohamed; Bjj Abdullah; D A Singh; K S Heng
Journal:  Biomed Imaging Interv J       Date:  2006-07-01

7.  Axillary pilonidal sinus: A case report.

Authors:  Ilker Sengul; Demet Sengul; Gamze Mocan
Journal:  N Am J Med Sci       Date:  2009-11

8.  Squamous cell carcinoma arising from chronic sacrococcygeal pilonidal disease: a case report.

Authors:  Nick Michalopoulos; Konstantinos Sapalidis; Styliani Laskou; Evangelia Triantafyllou; Georgia Raptou; Isaak Kesisoglou
Journal:  World J Surg Oncol       Date:  2017-03-17       Impact factor: 2.754

9.  Squamous cell carcinoma over pilonidal chronic disease. A new therapeutic approach.

Authors:  A Mayol Oltra; E Boldó Roda; R Lozoya Albacar; V Morillo Macias; N Nobleja Quiles
Journal:  Int J Surg Case Rep       Date:  2020-05-11

10.  35-year Onset of a Squamous Cell Carcinoma Originating from Sacral Pilonidal Sinus.

Authors:  Burak Ozkan; Harun Cologlu; Cagri A Uysal; Nilgun M Ertas
Journal:  Plast Reconstr Surg Glob Open       Date:  2019-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.